PCK2 and breast carcinoma: Because higher expression of PEPCK‐M was found in ER+ breast cancer samples than in ER− breast cancer samples and ER+ breast cancer is the most common subtype,3 we evaluated the function of PCK2 in ER+ breast cancer.